RARA CRAFT DATABASE for FDA Medical Devices
510(k)K230169

FDA DEVICE FACTS

EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert

Encore Medical, L.P Dba Enovis

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 6, 2023PRODUCT CODEJWH

Indications for use

Joint replacement is indicated for patients suffering from disability due to:

• degenerative, post-traumatic or rheumatoid arthritis;

• avascular necrosis of the femoral condyle;

• post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy;

• moderate valgus, varus or flexion deformities;

• treatment of fractures that are unmanageable using other techniques. This device may also be indicated in the salvage of previously failed surgical attempts. All devices are intended for cemented applications except for the 3DKNEE ™ Porous Coated Femur, EMPOWR 3DKNEE ™ POROUS Femur, and EMPOWR POROUS Tibia which are intended for cementless applications. While knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. The EMPOWR Revision VVC+, e+ Tibial Insert should be considered for use in total knee arthroplasty for patients under the following indications:

• absence or loss of both cruciate ligaments

• moderate varus-valgus or flexion instability that requires a bearing surface with increased constraint in the clinical judgement of the surgeon

• bone loss that requires supplemental fixation in the clinical judgement of the surgeon

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026